Mandate

Vinge advises EQT X in connection with its investment in HVD Group and Next One Technology

Vinges advises the EQT X fund (or “EQT Private Equity”) in connection with its investment in the Nordic software companies HVD Group (Hantverksdata) and Next (Next One Technology). Both companies serve the tradespeople and construction industry, with HVD Group focused on installation and service professions – such as electricians, plumbers, heating and ventilation firms – while Next is focused on contractors. HVD Group’s platform complements that of Next, and the investment thus paves the way for a further strengthened product offering, which builds on both companies’ strong customer satisfaction scores.

EQT Private Equity will invest in HVD Group and Next together with the existing HVD Group shareholder Adelis, who will increase its investment in the new combined company.

Both transactions are expected to close in February 2024.

Vinge’s team consisted of Christina Kokko, Karl Klackenberg, Elsie Nassar, Amanda Steen, Maximilian Bengtsson and Jonatan Stentorp (M&A), Louise Brorsson Salomon and Jolinn Uhlin (Financing), Marcus Glader, Daniel Wendelsson, Sebastian Örndahl, David Olander and Adam Löfquist (Regulatory), Axel Lennartsson (IPR), Mathilda Persson, Jolene Reimerson, Lisa Hörnqvist and Mario Saad (IT / GDPR), Christoffer Nordin, Carl Lexenberg and Arthur Kinski (Agreements), Emil Lindwall and Victor Björkheim (Employment) and Emelie Schoning (Transaction Support Coordinator).

Read the client's press release

 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025